• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Vaping less harmful than smoking for vascular health, major study finds

Bioengineer by Bioengineer
November 15, 2019
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study finds significant improvements in vascular health of chronic smokers who transition to e-cigarettes

IMAGE

Credit: Dominic Glasgow / University of Dundee

  • Study finds significant improvements in vascular health of chronic smokers who transition to e-cigarettes
  • Women see greater health benefits than men following switch to e-cigarettes
  • VESUVIUS is the largest study to-date on the vascular impact of e-cigarettes versus tobacco cigarettes

Cigarette smokers who switch to nicotine containing vaporisers could significantly improve their vascular health, a major University of Dundee study has concluded.

A two-year trial hosted by the University’s School of Medicine found that smokers who switched to e-cigarettes demonstrated a significant improvement in their vascular health within four weeks, with women experiencing greater gains by switching than men. The study also found that participants who transitioned achieved greater improvement compared to those who continued to use both tobacco cigarettes and e-cigarettes.

Named VESUVIUS, the British Heart Foundation-commissioned study is believed to have been the largest undertaken to-date in determining the impact of e-cigarettes on heart health, with the findings published by the Journal of the American College of Cardiology.

Professor Jacob George, Professor of Cardiovascular Medicine and Therapeutics at Dundee and Chief Investigator of the trial, said that while e-cigarettes were found to be less harmful, the devices may still carry health risks.

“It is crucial to emphasise that e-cigarettes are not safe, just less harmful than tobacco cigarettes when it comes to vascular health. Smoking of any kind is a preventable risk factor for heart disease.

“They should not be seen as harmless devices for non-smokers or young people to try. However, for chronic tobacco smokers there were significant improvements in vascular function within a month of switching from a tobacco cigarette to an e-cigarette.

“To put into context, each percentage point improvement in vascular function results in a 13% reduction in cardiovascular event rates such as heart attack. By switching from cigarettes to e-cigarettes we found an average percentage point improvement of 1.5 within just one month. This represents a significant improvement in vascular health. We also found that, in the short term at least, regardless of whether the e-cigarette does or does not contain nicotine, a person will see vascular health improvements compared to smoking a traditional cigarette. The longer term impact of nicotine requires further study and follow-up.

“Women benefitted significantly more than men by making the switch to e-cigarettes, and we are still looking into the reasons for this. Our research also revealed that if a person had smoked less than 20 pack years, their blood vessel stiffness also significantly improved compared to those who smoked more than 20 pack years.”

The VESUVIUS study recruited 114 long-term cigarette smokers who had smoked at least 15 cigarettes per day for at least two years. Participants were allocated to one of three groups for one month: Those who continued smoking tobacco cigarettes, those who switched to e-cigarettes with nicotine and those who switched to e-cigarettes without nicotine. Participants were monitored throughout the test period while undergoing vascular testing before and after the trial.

According to UK Government statistics, approximately 6% of Britain’s adult population use a vaporiser, though previously the impact of the devices on vascular health have been unclear. While the majority of e-cigarette liquids contain nicotine, they do not contain tobacco, which is claimed to have caused more than 7.1 million deaths worldwide in 2016. The number of additional chemicals is also typically much lower than those found in cigarettes.

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, said, “Our hearts and blood vessels are the hidden victims of smoking. Every year in the UK, 20,000 people die from heart and circulatory disease caused by smoking cigarettes – that’s more than 50 people a day, or two deaths every hour. Stopping smoking is the single best thing you can do for your heart health.

“This study suggests that vaping may be less harmful to your blood vessels than smoking cigarettes. Within just one month of ditching tobacco for electronic cigarettes, people’s blood vessel health had started to recover.

“Just because e-cigarettes may be less harmful than tobacco doesn’t mean they are completely safe. We know they contain significantly fewer of the harmful chemicals, which can cause diseases related to smoking, but we still don’t know the long term impact on the heart and circulation, or other aspects of health. E-cigarettes and vaping should never be taken up by people who don’t already smoke, but could be a useful tool to help people to stop smoking completely.”

Meanwhile, Scotland’s Public Health Minister, Joe FitzPatrick MSP, said, “I welcome the publication of this report, which contributes to the ongoing debate about the place of e-cigarettes in our communities. It is good to see important and relevant studies like this being produced in Scotland – justifying our reputation as being one of the leading centres for medical research.

“While research shows that switching to e-cigarettes can lead to vascular health benefits for chronic tobacco smokers, access to e-cigarettes needs to be controlled carefully – they are simply not products for children or non-smokers.”

###

The findings, obtainable via this link, will be published by the Journal of the American College of Cardiology at 7pm GMT on Friday 15 November

Media Contact
Jonathan Watson
[email protected]
038-213-85131

Related Journal Article

http://dx.doi.org/10.1016/j.jacc.2019.09.067

Tags: cancerCarcinogensCardiologyClinical TrialsMedicine/HealthPublic HealthResearch/DevelopmentSmoking/TobaccoTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Ongoing Use of Nasogastric Tubes Following Esophageal Cancer Surgery Receives Backing

Ongoing Use of Nasogastric Tubes Following Esophageal Cancer Surgery Receives Backing

July 31, 2025
RIPK1 S213E Mutation Blocks Cell Death Interactions

RIPK1 S213E Mutation Blocks Cell Death Interactions

July 31, 2025

Biomarker Panels Boost Atrial Fibrillation Risk Insights

July 31, 2025

Brain Imaging Could Predict Which Patients Will Benefit Most from Anxiety Care Apps

July 31, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Proteogenomic Study of Healthy vs. Cancerous Prostate Tissues Leveraging SILAC and Mutation Databases

Here’s a rewritten version of the headline for a science magazine post: “Could Desert Dust Hold the Key to Freezing Clouds?”

Lightning strikes kill 320 million trees annually, causing significant biomass loss

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.